DNAPrint Genomics, Inc.
DNAG
Rank in Stocks
#35171
DNAPrint Genomics, Inc. focuses on pioneering and distributing genetic analysis... DNAPrint Genomics, Inc. focuses on pioneering and distributing genetic analysis solutions and services. Their product portfolio includes AncestryByDNA, a comprehensive chromosomal assay for tracing genetic lineage, and EurasianDNA, designed to identify specific European ancestral subdivisions. They also offer EuropeanDNA, which outlines an individual's fundamental continental European heritage. In forensic science, DNAWitness assists in determining genetic background from crime scene samples, while RETINOME is utilized by detectives to construct physical traits, such as eye color, from DNA evidence or human remains. Furthermore, the company provides the GenomeLab SNPstream Genotyping System, recognized for its high genotyping throughput, multiplexing capabilities, and efficient reagent usage. DNAPrint Genomics caters to diverse clients in fields like forensic investigation, genealogical exploration, consumer products, and pharmaceutical research. Originally incorporated in 1983 as Lexington Energy, Inc., the company operates from Sarasota, Florida, with an international presence through a subsidiary in Leverkusen, Germany.
Share Price
$0.000001
Last synced: 2026-11-09
Market Cap
$630.33
Change (1 day)
-95.00%
Change (1 year)
-90.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade DNAPrint Genomics, Inc. (DNAG)
Category
Healthcare
EPS for DNAPrint Genomics, Inc. (DNAG)
EPS as of September 2007 TTM: $-0.01
According to DNAPrint Genomics, Inc.'s latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2006 the company had an EPS of $-0.03, an increase over its 2005 EPS of $-0.09.
EPS history for DNAPrint Genomics, Inc. from 2001 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -83.33% |
| 2006 | $-0.03 | -66.67% |
| 2005 | $-0.09 | -55.00% |
| 2004 | $-0.20 | -93.75% |
| 2003 | $-3.20 | 2,185.71% |
| 2002 | $-0.14 | -30.00% |
| 2001 | $-0.20 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -313,300.00% |
US
|
|
| $-7.07 | 141,300.00% |
US
|
|
| $-5.29 | 105,700.00% |
AU
|
|
| $12.88 | -257,702.00% |
BE
|
|
| $21.56 | -431,300.00% |
NL
|
Questions about DNAPrint Genomics, Inc.'s earnings per share (EPS)
What is DNAPrint Genomics, Inc.'s earnings per share (EPS)?
DNAPrint Genomics, Inc.'s earnings per share (EPS) over the last twelve months is $-0.01, as of Sep 2007.
What was DNAPrint Genomics, Inc.'s earnings per share (EPS) in 2006?
In 2006, DNAPrint Genomics, Inc.'s earnings per share (EPS) was $-0.03, compared with $-0.09 in 2005.
How has DNAPrint Genomics, Inc.'s earnings per share (EPS) changed since 2001?
From 2001 to 2006, DNAPrint Genomics, Inc.'s earnings per share (EPS) was highest in 2006 ($-0.03) and lowest in 2003 ($-3.20).
How does DNAPrint Genomics, Inc.'s earnings per share (EPS) compare with similar companies?
DNAPrint Genomics, Inc.'s earnings per share (EPS) ($-0.01) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.